CytomX Therapeutics Inc (CTMX)
1.07
-0.02
(-1.83%)
USD |
NASDAQ |
Dec 24, 16:00
CytomX Therapeutics Free Cash Flow: -88.78M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Spero Therapeutics Inc | -17.54M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.73M |
| Cash from Investing (Quarterly) | 18.17M |
| Free Cash Flow Per Share (Quarterly) | -0.2435 |
| Free Cash Flow to Equity (Quarterly) | -20.75M |
| Free Cash Flow to Firm (Quarterly) | -20.75M |
| Free Cash Flow Yield | -99.29% |